Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer.

Gorgisen, Gokhan; Hapil, Fatma Zehra; Yilmaz, Ozlem; Cetin, Zafer; Pehlivanoglu, Suray; Ozbudak, Irem Hicran; Erdogan, Abdullah; Ozes, Osman Nidai

Gorgisen, Gokhan; Hapil, Fatma Zehra; Yilmaz, Ozlem; Cetin, Zafer; Pehlivanoglu, Suray; Ozbudak, Irem Hicran; Erdogan, Abdullah; Ozes, Osman Nidai.

Afiliação

Gorgisen G; Faculty of Medicine, Van Yuzuncu Yil University, Turkey.
Hapil FZ; Izmir Biotechnology and Genome Center, Izmir, Turkey.
Yilmaz O; Faculty of Medicine, Akdeniz University, Antalya, Turkey.
Cetin Z; Faculty of Medicine, Sanko University, Gaziantep, Turkey.
Pehlivanoglu S; Faculty of Science, Necmettin Erbakan University, Konya, Turkey.
Ozbudak IH; Faculty of Medicine, Akdeniz University, Antalya, Turkey.
Erdogan A; Faculty of Medicine, Akdeniz University, Antalya, Turkey.
Ozes ON; ALTAY Biopharma, San Bruno, CA, USA.

Genet Mol Biol ; 42(1): 15-25, 2019.

Article em En | MEDLINE | ID: mdl-30807634

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Genet Mol Biol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google